Docquity and AstraZeneca’s Patient Support Program Educates Tens of Thousands in Thailand
BANGKOK, THAILAND, 22 April 2025 – Docquity, Southeast Asia’s largest community of healthcare professionals (HCPs), and global biopharmaceutical leader AstraZeneca developed OAZisCare, an end-to-end patient support program (PSP) that improves cancer care and enhanced Respiratory Syncytial Virus (RSV) vaccine education and adherence in Thailand. Developed in 2024 as a digital support program for patients and …